JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403072200 on June 1, 2004

J. Biol. Chem., Vol. 279, Issue 32, 33593-33600, August 6, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/32/33593    most recent
M403072200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, F. S.
Right arrow Articles by Bratt, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, F. S.
Right arrow Articles by Bratt, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Insertion of Foreign T Cell Epitopes in Human Tumor Necrosis Factor {alpha} with Minimal Effect on Protein Structure and Biological Activity*

Finn Stausholm Nielsen{ddagger}§, Jørgen Sauer¶, Johan Bäcklund{ddagger}, Bjørn Voldborg{ddagger}, Klaus Gregorius||, Søren Mouritsen{ddagger}, and Tomas Bratt{ddagger}

From the {ddagger}Pharmexa A/S, Kogle Allé 6, DK-2970 Hørsholm, Denmark, the ALK-Abelló A/S Bøge Allé 6-8, DK-2970 Hørsholm, Denmark, and ||PreciSense A/S Dr. Neergaards Vej 3, DK-2970 Hørsholm, Denmark

To create a human therapeutic vaccine able to circumvent self-tolerance against tumor necrosis factor (TNF) {alpha}, foreign T helper epitopes were inserted into human TNF{alpha}, with minimal effect on the native three-dimensional structure. TNF{alpha} variants were screened for solubility, structural stability, biological activity, and after immunization, for eliciting inhibitory antibodies. The longest and most flexible loop in TNF{alpha}, also designated loop 3, is the only region that is not involved in intra- or intermolecular interactions and therefore constitute an attractive insertion site. However, the extension of the flexible loop by epitope insertions destabilized the TNF{alpha} molecule. Therefore, two cysteines were introduced to form a stabilizing disulfide bond between loops 2 and 3. In a second design approach, three TNF{alpha} monomers were linked by two T cell epitopes and expressed as a single chain TNF{alpha} trimer. TNF{alpha} variants that were expressed as soluble proteins also had a conserved tertiary structure, as determined by circular dichroism. The biological activity of the TNF{alpha} variants was of the same magnitude as human TNF{alpha} in cellular assays. Introduction of three separate single-point mutations (D143N, A145R, or Y87S) diminished the cytotoxicity of the mutated variants 50-800-fold compared with native TNF{alpha}. Antisera from mice immunized with the different TNF{alpha} variants were able to cross-react with native human TNF{alpha} and to inhibit TNF{alpha} signaling via the TNF receptors in vitro, suggesting that the structural binding epitopes of native human TNF{alpha} and thus the native conformation were conserved in the constructed vaccine candidates.


Received for publication, March 19, 2004 , and in revised form, May 26, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 45-45-16-25-25; Fax: 45-45-16-25-00; E-mail: fn{at}pharmexa.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Krippner-Heidenreich, I. Grunwald, G. Zimmermann, M. Kuhnle, J. Gerspach, T. Sterns, S. D. Shnyder, J. H. Gill, D. N. Mannel, K. Pfizenmaier, et al.
Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity
J. Immunol., June 15, 2008; 180(12): 8176 - 8183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.